Cancer is "an evolutionary disease," writes Carl Zimmer at the New York Times. Treat it with one drug, see an improvement, but then it finds a way around the treatment to recur. Johns Hopkins University's Bert Vogelstein, he adds, is using mathematics to model such resistances and recurrence.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.